CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 25th Annual JPMorgan Healthcare Conference on January 9, 2007 at 1:30 p.m. PT (4:30 p.m. ET) at the Westin St. Francis Hotel in San Francisco.
